Error: Could not add to watchlist. X

CSL Ltd

+ Watchlist
CSL:AU
ASE
88.14
AUD
1.72
1.91%
As of 02:10:55 ET on 07/03/2015.
Open
89.13
Day Range
87.49 - 89.49
Volume
1,060,566
Previous Close
89.86
52Wk Range
63.77 - 96.60
1 Yr Return
30.88%
Current P/E Ratio (TTM)
23.40
Earnings per Share (USD) (TTM)
2.83
Market Cap (b AUD)
40.970
Shares Outstanding (m)
464.829
Price/Sales (TTM)
5.76
Dividend Indicated Gross Yield
1.58%
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
Profile
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.
ADDRESS
45 Poplar Road
Parkville, VIC 3052
Australia
PHONE
61-3-9389-1911
  • John Shine
    Chairman
  • Paul Perreault
    CEO/Managing Director
  • Gordon Naylor
    Chief Financial Officer
  • Mary Sontrop
    Exec VP:Manufacturing
  • Gregory Boss "Greg"
    Exec VP:Legal/Gen Cnsl
Show More